Results 11 to 20 of about 115,113 (195)

Classical autoimmune hepatitis and the IgG4-associated autoimmune hepatitis in paediatric patients

open access: yesPolish Journal of Pathology
The IgG4-associated autoimmune hepatitis (IgG4-AIH) is a newly proposed disease entity characterised by the accumulation of the IgG4-expressing plasma cells in the liver. Its pathophysiology and clinical significance remain unclear and have poor evidence
Dominika Kaps-Kopiec   +6 more
doaj   +2 more sources

Smoking is a Risk Factor for Autoimmune Hepatitis: An English Registry-Based Case–Control Study

open access: yesClinical Epidemiology
Lisbet Grønbæk,1– 3 Harmony Omeife,3 Lu Ban,4 Colin J Crooks,5 Timothy R Card,3,4 Peter Jepsen,1,3 Joe West3,4,6 1Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Medicine, Regional Hospital ...
Grønbæk L   +6 more
doaj   +1 more source

Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1:A Landmark Analysis [PDF]

open access: yes, 2022
Background & Aims: Biochemical remission, important treatment goal in autoimmune hepatitis (AIH), has been associated with better long-term survival.
Sermon, F.   +27 more
core   +1 more source

Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group [PDF]

open access: yes, 2022
Background & aims: Autoimmune hepatitis (AIH) has been well characterised and codified through the development of diagnostic criteria. These criteria have been adapted and simplified and are widely used in clinical practice.
Montano-Loza, Aldo J   +17 more
core   +1 more source

Anti-ribosomal P (anti-P) antibodies in patients with autoimmune hepatitis

open access: yesEinstein (São Paulo), 2023
Objective Published studies have shown associations between anti-ribosomal P (anti-P) antibody and systemic lupus erythematosus with hepatic manifestations. This has been reported also in autoimmune hepatitis.
Clarisse de Almeida Gallo   +6 more
doaj   +1 more source

New treatments/targets for primary biliary cholangitis

open access: yesJHEP Reports, 2019
Summary: Primary biliary cholangitis (PBC) is an autoimmune, cholestatic, chronic liver disease that ultimately progresses towards cirrhosis and liver failure if untreated.
Christophe Corpechot   +2 more
doaj   +1 more source

Case Report: Viral Pneumonia Could Prompt the Advancement of Immune-Mediated Liver Disease

open access: yesFrontiers in Medicine, 2021
Background: The impact of the influenza A (H1N1) and SARS-CoV-2 virus on the development of autoimmune hepatitis has not been described previously.Methods: In this case series, we evaluated the dynamic changes in liver function of three patients with ...
Qian Li   +9 more
doaj   +1 more source

Hepatitis induced by noni juice from Morinda citrifolia: A rare cause of hepatotoxicity or the tip of the iceberg? [PDF]

open access: yes, 2006
A 24-year-old female patient presented to her community hospital with mild elevations of serum transaminase and bilirubin levels. Because of multiple sclerosis, she was treated with interferon beta-la for 6 weeks.
Yuece, B.   +3 more
core   +1 more source

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection [PDF]

open access: yes, 2008
Autoimmune liver diseases, such as autoimmune hepatitis (AIH) and primary biliary cirrhosis, often have severe consequences for the patient. Because of a lack of appropriate animal models, not much is known about their potential viral etiology. Infection
Hintereder, Gudrun   +23 more
core   +1 more source

Autoimmune hepatitis

open access: yesJournal of Hepatology, 2000
Autoimmune hepatitis (AIH) is a rare disease, characterized by female predominance, hypergammaglobulinemia, autoantibodies, association with HLA DR3 and HLA DR4 and a good response to immunosuppression. Different subtypes of AIH may be distinguished, based on differences in the autoantibody patterns.
P, Obermayer-Straub   +2 more
  +7 more sources

Home - About - Disclaimer - Privacy